These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26371624)

  • 1. Therapeutic advances in restless legs syndrome (RLS).
    Högl B; Comella C
    Mov Disord; 2015 Sep; 30(11):1574-9. PubMed ID: 26371624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)
    Winkelmann J; Allen RP; Högl B; Inoue Y; Oertel W; Salminen AV; Winkelman JW; Trenkwalder C; Sampaio C
    Mov Disord; 2018 Jul; 33(7):1077-1091. PubMed ID: 29756335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sleep and sleep disorders in the elderly: Part 3: Restless legs syndrome].
    Frohnhofen H; Schlitzer J
    Z Gerontol Geriatr; 2015 Jun; 48(4):379-87; quiz 388. PubMed ID: 26025498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
    Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
    Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects.
    de Biase S; Merlino G; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1035-45. PubMed ID: 27310338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targinact for restless legs syndrome.
    Drug Ther Bull; 2016 Apr; 54(4):42-5. PubMed ID: 27079737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restless legs syndrome.
    Yee B; Killick R; Wong K
    Aust Fam Physician; 2009 May; 38(5):296-300. PubMed ID: 19458798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome.
    Oertel WH; Trenkwalder C; Zucconi M; Benes H; Borreguero DG; Bassetti C; Partinen M; Ferini-Strambi L; Stiasny-Kolster K
    Mov Disord; 2007; 22 Suppl 18():S466-75. PubMed ID: 17516455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1365-80. PubMed ID: 25149093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restless legs: recent advances in basic research and therapy].
    Sieb JP
    Med Monatsschr Pharm; 2010 Apr; 33(4):133-9. PubMed ID: 20429403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current guidelines and standards of practice for restless legs syndrome.
    Hening WA
    Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restless legs syndrome: understanding its consequences and the need for better treatment.
    Earley CJ; Silber MH
    Sleep Med; 2010 Oct; 11(9):807-15. PubMed ID: 20817595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
    García-Borreguero D
    Sleep Med Clin; 2015 Sep; 10(3):287-92, xiii. PubMed ID: 26329438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep Disorders: Restless Legs Syndrome.
    Burman D
    FP Essent; 2017 Sep; 460():29-32. PubMed ID: 28845959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain, opioids, and sleep: implications for restless legs syndrome treatment.
    Trenkwalder C; Zieglgänsberger W; Ahmedzai SH; Högl B
    Sleep Med; 2017 Mar; 31():78-85. PubMed ID: 27964861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.